Pelikan Sun
This article was originally published in The Gray Sheet
Executive Summary
Electronically controlled, fully automated lancing system will be unveiled at the June American Diabetes Association Scientific Sessions in New Orleans. Designed to reduce pain associated with blood sample collection, the device will launch in "early 2004" in the U.S., Pelikan Technologies says. The firm gained 510(k) clearance April 23. A second-generation system that combines the lancet with glucose measurement capability is expected in 2005...